$27.03
At close: Sep 25, 5:00 PM EST
$27.10
0.07190.27%
After Hours: Jul 17, 9:29 AM EST
Defiance Autism Impact ETF (ASD) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
1.37M
Fund Score
Loading...
Key Statistics
Open
-
High
-
52 Wk High
$28.52
AUM
1.37M
Dividend
$0.02
Ex-Div Date
Sep 23, 2026
Volume
-
Market Cap
$99.61B
Mgmt Fee
0.79%
P/E Ratio
23.82
Prev. Close
$27.03
Low
-
52 Wk Low
$24.59
Shares Out
75.00K
Yield
0.06%
Div. Freq
-
Avg. Volume Daily
211.00
Beta
1.90
Avg. Expense Ratio
0.79%
P/B Ratio
2.38
Recent Defiance Autism Impact ETF News
FAQ
Q
How do I buy Defiance Autism Impact ETF (ASD) stock?
A
You can purchase shares of Defiance Autism Impact ETF (NASDAQ:ASD) through any online brokerage.
Q
Who are Defiance Autism Impact ETF (ASD) competitors?
A
There are no as such competitors for Defiance Autism Impact ETF.
Q
What is the forecast, or price target, for Defiance Autism Impact ETF (ASD) stock?
A
There is no analysis for Defiance Autism Impact ETF to provide a consensus price target.
Q
What is the current price for Defiance Autism Impact ETF (ASD)?
A
The stock price for Defiance Autism Impact ETF (NASDAQ: ASD) is $27.1 last updated July 17, 2026 at 9:29 AM EDT.
Q
Does Defiance Autism Impact ETF (ASD) pay a dividend?
A
There are no upcoming dividends for Defiance Autism Impact ETF.
Q
When is Defiance Autism Impact ETF (NASDAQ:ASD) reporting earnings?
A
Defiance Autism Impact ETF does not have any upcoming earnings scheduled.
Q
Is Defiance Autism Impact ETF (ASD) going to split?
A
There is no upcoming split for Defiance Autism Impact ETF.
Key Statistics
Open
-
High
-
52 Wk High
$28.52
AUM
1.37M
Dividend
$0.02
Ex-Div Date
Sep 23, 2026
Volume
-
Market Cap
$99.61B
Mgmt Fee
0.79%
P/E Ratio
23.82
Prev. Close
$27.03
Low
-
52 Wk Low
$24.59
Shares Out
75.00K
Yield
0.06%
Div. Freq
-
Avg. Volume Daily
211.00
Beta
1.90
Avg. Expense Ratio
0.79%
P/B Ratio
2.38
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Value |
| Fund Inception | Jun 1, 2026 |
| Managers | Christine Johanson Dustin Lewellyn Ernesto Tong |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
To achieve its investment objective primarily The Fund uses a passive management (or indexing) approach to track the total return performance, before fees and expenses, of the Index.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| CA | Definium Therapeutics,... | 4.04% |
| LFST | LifeStance Health Grou... | 3.76% |
| ACAD | Acadia Pharmaceuticals... | 3.11% |
| NZ | Neuren Pharmaceuticals... | 3.81% |
| RGEN | Repligen Corp | 3.05% |
| ZA | Life Healthcare Group ... | 2.81% |
| RVTY | Revvity Inc | 3.07% |
| BMRN | Biomarin Pharmaceutica... | 2.89% |
| TK | Sumitomo Pharma Co., L... | 2.82% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved